Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-29
DOI
10.3389/fimmu.2018.01051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis
- (2018) Shaleen R. Vasavada et al. JOURNAL OF UROLOGY
- The combination of histological prostate atrophy and inflammation is associated with lower risk of prostate cancer in biopsy specimens
- (2017) D M Moreira et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study
- (2016) S E T Larkin et al. BRITISH JOURNAL OF CANCER
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
- (2016) Daniela Siegmund et al. Cell Death & Disease
- The role of inflammatory cytokines and ERK1/2 signaling in chronic prostatitis/chronic pelvic pain syndrome with related mental health disorders
- (2016) Chao Hu et al. Scientific Reports
- Pyrrolidine Dithiocarbamate Inhibits NF-KappaB Activation and Upregulates the Expression of Gpx1, Gpx4, Occludin, and ZO-1 in DSS-Induced Colitis
- (2015) Jie Yin et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
- (2015) K L Mahon et al. BRITISH JOURNAL OF CANCER
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
- (2015) Alassane Mbengue et al. NATURE
- Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis
- (2015) Haiyan Tan et al. Oncotarget
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells
- (2014) Xiaofeng Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
- (2014) I. Theate et al. Cancer Immunology Research
- Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
- (2013) Rikke B. Holmgaard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6->Androgen Receptor->TGF- ->MMP-9 Signals
- (2013) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Tumor necrosis factor
- (2012) Wen-Ming Chu CANCER LETTERS
- Signal transduction by tumor necrosis factor receptors
- (2012) Lucía Cabal-Hierro et al. CELLULAR SIGNALLING
- Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
- (2012) Chun-Te Wu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Myoblasts Inhibit Prostate Cancer Growth by Paracrine Secretion of Tumor Necrosis Factor-α
- (2012) Meline Nogueira Lucena Stölting et al. JOURNAL OF UROLOGY
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis
- (2011) Y. Cao et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer
- (2011) Chantal Mengus et al. Journal of Translational Medicine
- Cytokine disbalance in common human cancers
- (2010) Zoran Culig BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
- (2010) T. B. Dorff et al. CLINICAL CANCER RESEARCH
- Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status
- (2010) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF CANCER
- High expression of indoleamine 2,3-dioxygenase gene in prostate cancer
- (2008) Chantal Feder-Mengus et al. EUROPEAN JOURNAL OF CANCER
- The Role of P38 MAPK and PKC in BLP Induced TNF-α Release, Apoptosis, and NFκB Activation in THP-1 Monocyte Cells
- (2008) Adrian W. O'Sullivan et al. JOURNAL OF SURGICAL RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- How tumours escape mass destruction
- (2008) T J Stewart et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started